Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Haniya Rehman"'
Autor:
Diane M. Robins, Haniya Rehman, Michele Brogley, Megan A. Albertelli, Mara P. Steinkamp, Orla A. O'Mahony
Gain-of-function mutations in the androgen receptor (AR) are found in prostate cancer and are implicated in the failure of hormone therapy. Most studies have emphasized the ligand-binding domain (LBD) where mutations can create promiscuous receptors,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ece546e3d35ffcfdca6b7db865316f5
https://doi.org/10.1158/1541-7786.c.6541447.v1
https://doi.org/10.1158/1541-7786.c.6541447.v1
Autor:
Diane M. Robins, Haniya Rehman, Michele Brogley, Megan A. Albertelli, Mara P. Steinkamp, Orla A. O'Mahony
Supplementary Tables S1-S2 from Profiling Human Androgen Receptor Mutations Reveals Treatment Effects in a Mouse Model of Prostate Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e12050e09343ce0620af085e8321a4e
https://doi.org/10.1158/1541-7786.22516693
https://doi.org/10.1158/1541-7786.22516693
Autor:
Diane M. Robins, Kenneth J. Pienta, Mark A. Rubin, Arul Chinnaiyan, Rainer Kuefer, Matthias D. Hofer, Saravana Dhanasekaran, Elizabeth W. LaPensee, Haniya Rehman, Michele Brogley, Orla A. O'Mahony, Mara P. Steinkamp
Supplementary Figure 2 from Treatment-Dependent Androgen Receptor Mutations in Prostate Cancer Exploit Multiple Mechanisms to Evade Therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0456cd82e064803071fe4e8f6de20ab0
https://doi.org/10.1158/0008-5472.22378194
https://doi.org/10.1158/0008-5472.22378194
Autor:
Diane M. Robins, Kenneth J. Pienta, Mark A. Rubin, Arul Chinnaiyan, Rainer Kuefer, Matthias D. Hofer, Saravana Dhanasekaran, Elizabeth W. LaPensee, Haniya Rehman, Michele Brogley, Orla A. O'Mahony, Mara P. Steinkamp
Supplementary Figure 1 from Treatment-Dependent Androgen Receptor Mutations in Prostate Cancer Exploit Multiple Mechanisms to Evade Therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88aed770ee61f9c91a8d96618aae8851
https://doi.org/10.1158/0008-5472.22378197
https://doi.org/10.1158/0008-5472.22378197
Publikováno v:
Journal of Mammalian Ova Research. 29:17-21
Parthenogenesis is the process by which an oocyte develops into an embryo without fertilization. Parthenogenetic activation can be performed at various stages of meiosis, yielding embryos with a distinct genetic pattern of homozygousity and heterozyg
Autor:
Geneviève Almouzni, Leanne De Koning, Alexia Savignoni, Charlène Boumendil, Xavier Sastre-Garau, Bernard Asselain, Haniya Rehman
Publikováno v:
EMBO Molecular Medicine
Mammalian cells contain three closely related heterochromatin protein 1 (HP1) isoforms, HP1alpha, beta and gamma, which, by analogy to their unique counterpart in Schizosaccharomyces pombe, have been implicated in gene silencing, genome stability and
Autor:
Arul M. Chinnaiyan, Diane M. Robins, Elizabeth LaPensee, Mark A. Rubin, Haniya Rehman, Mara P. Steinkamp, Rainer Kuefer, Matthias D. Hofer, Kenneth J. Pienta, Michele Brogley, Orla A. O'Mahony, Saravana M. Dhanasekaran
Publikováno v:
Cancer Research. 69:4434-4442
Mutations in the androgen receptor (AR) that enable activation by antiandrogens occur in hormone-refractory prostate cancer, suggesting that mutant ARs are selected by treatment. To validate this hypothesis, we compared AR variants in metastases obta
Autor:
Elise Martel, Leanne De Koning, Isabelle Vassias, Alexia Savignoni, Fabien Reyal, Geneviève Almouzni, Armelle Corpet, Xavier Sastre-Garau, Bernard Asselain, Haniya Rehman, Laurence O.W. Wilson, Rocío Montes de Oca, Zachary A. Gurard-Levin, Didier Meseure, Frédérique Berger
Publikováno v:
Molecular oncology. 9(3)
Background Breast cancer is a heterogeneous disease with different molecular subtypes that have varying responses to therapy. An ongoing challenge in breast cancer research is to distinguish high-risk patients from good prognosis patients. This is pa
Autor:
Mara P. Steinkamp, Orla A. O'Mahony, Diane M. Robins, Michele Brogley, Megan A. Albertelli, Haniya Rehman
Gain-of-function mutations in the androgen receptor (AR) are found in prostate cancer and are implicated in the failure of hormone therapy. Most studies have emphasized the ligand-binding domain (LBD) where mutations can create promiscuous receptors,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa5b6bc35e8a279a9678cea08f42c5b9
https://europepmc.org/articles/PMC2748651/
https://europepmc.org/articles/PMC2748651/